Shandong Xinjufeng Technology Packaging (301296) Q2 2025 earnings summary

Executive summary

• Revenue for the first half of 2025 reached ¥1.25 billion, up 52.29% year-over-year, driven by business expansion and the consolidation of acquired subsidiaries.

• Net profit attributable to shareholders was ¥59.0 million, down 31.36% year-over-year, mainly due to increased costs and financial expenses from acquisitions.

• The company completed the acquisition of a controlling stake in a major packaging peer, enhancing market share and operational synergies.

• Major investments were made in production capacity and R&D, including the ongoing “50 Billion Aseptic Packaging Project” and the new Kunshan R&D Center.

Financial highlights

• Operating income: ¥1,253,330,791.28, up 52.29% year-over-year.

• Net profit attributable to shareholders: ¥59,000,549.68, down 31.36% year-over-year.

• Operating cash flow: -¥16,138,786.37, a significant decrease from ¥378,664,729.92 in the prior year.

• Gross margin: 21.88%, slightly down from 22.79% year-over-year.

• Total assets: ¥6,059,666,077.21, up 69.26% from year-end 2024.

Outlook and guidance

• The company expects the aseptic packaging market to recover in 2025, with a projected 4.2% CAGR over the next three years.

• Integration with the acquired subsidiary is expected to boost domestic market share above 20%, second only to the industry leader.

• Ongoing investments in production and R&D are aimed at supporting long-term growth and technological leadership.